Jordan Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.

Press releases published on July 6, 2026

an hour ago

Pluristyx Inc. Secures Initial Close of Series A Priced Round with Multinational Fortune 500 Company; Round to Remain Open for Syndicate Partners Until September 2nd

Indeterminate GlobeNewswire

an hour ago

Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA

Indeterminate GlobeNewswire

an hour ago

VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines

Indeterminate GlobeNewswire

an hour ago

Integrated Development Helps Targeted Protein Degraders Reach the Clinic

Indeterminate GlobeNewswire

an hour ago

Nephros Announces Inclusion in the Russell Microcap® Index

Indeterminate GlobeNewswire

an hour ago

NovMetaPharma and the FSHD Canada Foundation Establish Collaboration to Advance Cyclo-Z, a First-in-Class Oral Muscle-Preserving Therapy, into Facioscapulohumeral Muscular Dystrophy

Indeterminate GlobeNewswire

an hour ago

Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease

Indeterminate GlobeNewswire

an hour ago

NN, Inc. Announces Major Breakthrough in its Medical Business

Indeterminate GlobeNewswire

an hour ago

Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential

Indeterminate GlobeNewswire

an hour ago

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

Indeterminate GlobeNewswire

an hour ago

Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences

Indeterminate GlobeNewswire

an hour ago

Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027

Indeterminate GlobeNewswire

an hour ago

Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks

Indeterminate GlobeNewswire

2 hours ago

Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

Indeterminate GlobeNewswire

2 hours ago

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

Indeterminate GlobeNewswire

2 hours ago

AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder

Indeterminate GlobeNewswire

5 hours ago

Astex Announces Exclusive Research Collaboration and License Agreement with Genentech for Breast Cancer Therapy Program

Indeterminate GlobeNewswire

7 hours ago

Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform

Indeterminate GlobeNewswire

7 hours ago

Inside the World's First AGI Smart Health Cities: QAIAx AI City Hall Project (Veterans First for America)

Indeterminate GlobeNewswire

7 hours ago

REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION

Indeterminate GlobeNewswire